221 related articles for article (PubMed ID: 32582572)
41. Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.
Gallez-Hawkins G; Thao L; Lacey SF; Martinez J; Li X; Franck AE; Lomeli NA; Longmate J; Diamond DJ; Spielberger R; Forman SJ; Zaia JA
Biol Blood Marrow Transplant; 2005 Nov; 11(11):890-902. PubMed ID: 16275592
[TBL] [Abstract][Full Text] [Related]
42. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
Berger M; Wettstein PJ; Korngold R
Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
[TBL] [Abstract][Full Text] [Related]
43. Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread.
Holtappels R; Podlech J; Freitag K; Lemmermann NA; Reddehase MJ
Viruses; 2022 May; 14(6):. PubMed ID: 35746617
[TBL] [Abstract][Full Text] [Related]
44. Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients.
Kwun J; Hu H; Schadde E; Roenneburg D; Sullivan KA; DeMartino J; Burlingham WJ; Knechtle SJ
J Immunol; 2007 Dec; 179(12):8016-25. PubMed ID: 18056341
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
[TBL] [Abstract][Full Text] [Related]
46. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
Korngold R; Leighton C; Mobraaten LE; Berger MA
Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
[TBL] [Abstract][Full Text] [Related]
47. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation.
Hakki M; Riddell SR; Storek J; Carter RA; Stevens-Ayers T; Sudour P; White K; Corey L; Boeckh M
Blood; 2003 Oct; 102(8):3060-7. PubMed ID: 12843000
[TBL] [Abstract][Full Text] [Related]
48. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
49. Minor Histocompatibility Antigen-Specific T Cells.
Summers C; Sheth VS; Bleakley M
Front Pediatr; 2020; 8():284. PubMed ID: 32582592
[TBL] [Abstract][Full Text] [Related]
50. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
[TBL] [Abstract][Full Text] [Related]
51. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
[TBL] [Abstract][Full Text] [Related]
52. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.
Steffens HP; Kurz S; Holtappels R; Reddehase MJ
J Virol; 1998 Mar; 72(3):1797-804. PubMed ID: 9499030
[TBL] [Abstract][Full Text] [Related]
53. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
[TBL] [Abstract][Full Text] [Related]
54. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection.
Manley TJ; Luy L; Jones T; Boeckh M; Mutimer H; Riddell SR
Blood; 2004 Aug; 104(4):1075-82. PubMed ID: 15039282
[TBL] [Abstract][Full Text] [Related]
55. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.
Lacey SF; Diamond DJ; Zaia JA
Biol Blood Marrow Transplant; 2004 Jul; 10(7):433-47. PubMed ID: 15205665
[TBL] [Abstract][Full Text] [Related]
56. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
Marks L; Altman NH; Podack ER; Levy RB
Transplantation; 2004 Mar; 77(6):804-12. PubMed ID: 15077018
[TBL] [Abstract][Full Text] [Related]
57. Suppression of B-cell development as a result of selective expansion of donor T cells during the minor H antigen graft-versus-host reaction.
Garvy BA; Elia JM; Hamilton BL; Riley RL
Blood; 1993 Nov; 82(9):2758-66. PubMed ID: 8219228
[TBL] [Abstract][Full Text] [Related]
58. Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.
Smith C; Brennan RM; Tey SK; Smyth MJ; Burrows SR; Miles JJ; Hill GR; Khanna R
J Virol; 2016 Aug; 90(16):7497-507. PubMed ID: 27279616
[TBL] [Abstract][Full Text] [Related]
59. Minor H antigens: genes and peptides.
Simpson E; Scott D; James E; Lombardi G; Cwynarski K; Dazzi F; Millrain M; Dyson PJ
Transpl Immunol; 2002 Aug; 10(2-3):115-23. PubMed ID: 12216941
[TBL] [Abstract][Full Text] [Related]
60. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.
Asavaroengchai W; Wang H; Wang S; Wang L; Bronson R; Sykes M; Yang YG
Biol Blood Marrow Transplant; 2007 Jan; 13(1):46-55. PubMed ID: 17222752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
